Network and Advisory

Clinical network

Qvanteq’s FiM study is conducted in collaboration with 6 leading European interventional cardiology centers.

The centers are Universitätsklinik für Kardiologie Schweizer Herz- und Gefässzentrum Bern, Switzerland (PD Dr. L. Räber), Thoraxcenter Erasmus MC Universitair Medisch Centrum Rotterdam, Netherlands (Dr. J. Daemen), HerzKlinik Hirslanden Zürich, Switzerland (Prof. R. Corti), Cardiologie interventionnelle HUG – Hôpitaux Universitaires de Genève, Switzerland (Prof. M. Roffi), Stadtspital Triemli Zürich Klinik für Kardiologie Zürich, Switzerland (Prof. F. Eberle) and Thoraxcentrum Twente, Medisch Spectrum Twente Enschede, Netherlands (Prof. C. von Birgelen). The study chair is Prof. P. W Serruys, Erasmus Medical Center, Thoraxcenter, Rotterdam, Netherlands.

 

R&D network

The Qstent is developed in close collaboration with ETH Zürich, Switzerland (ETH Spinoff), University Zurich, Switzerland (Research group of Dr. M. Ehrbar) and the RMS Foundation Bettlach, Switzerland (Dr. R. Heuberger). Preclinical in-vitro and animal work was done at CBSET Inc. Lexington MA, USA (Prof. E. Edelman).

 

Support

Qvanteq AG has been supported by the following organizations:

   Druck